A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Amikacin has been studied across 16 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🔬 Oncology, 🫁 Respiratory, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 14% of studies addressing this area.
This evidence profile for Amikacin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.